Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.

Author information

Affiliations

  • 1. Department of Pathology, University of Chicago, Illinois 60637.
      Authors
    • Ward PL 1
    (1 author)

The Journal of Experimental Medicine, 01 Jul 1989, 170(1):217-232
https://doi.org/10.1084/jem.170.1.217 PMID: 2787379 PMCID: PMC2189372

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Abstract 

We have isolated UV light-induced and spontaneous tumors along with nonmalignant cells and tissues from each host. CD8+ CTL clones generated to a number of highly immunogenic UV-induced tumors did not react with autologous normal fibroblasts nor with autologous second tumors. Using up to 25 independently induced tumors as targets, these CTL clones were found to be uniquely specific for the particular tumor used for immunization even when multiple tumors isolated from the same animals were used as targets. In addition to this extensive antigenic diversity of independently induced tumors, we found that a single cancer cell can express multiple independent antigens that were uniquely expressed on the tumor but were not detectable on autologous nonmalignant fibroblasts. A poorly immunogenic spontaneous tumor was also found to express an antigen that was uniquely specific for the immunizing tumor in that it was absent from any of 25 other tumors tested. This antigen was recognized by a mAb and not detected on autologous nonmalignant fibroblasts or on an autologous second spontaneous tumor. These findings demonstrate that syngeneic CTL clones or mAbs can define unique antigens on UV-induced or spontaneous tumors. The use of autologous nonmalignant fibroblast targets made it unlikely that these antigens were widely expressed on normal cells. The availability of cloned immunological probes to antigens on tumors isolated with autologous normal cells will allow a reliable identification of the genetic origins of unique antigens on experimentally induced and spontaneous tumors and permit a decisive answer to whether these unique antigens are encoded by normal genes or by genes that have undergone somatic mutations; i.e., whether these antigens are truly tumor specific.

Free full text 

Logo of jexpmedLink to Publisher's site
J Exp Med. 1989 Jul 1; 170(1): 217–232.
PMCID: PMC2189372
PMID: 2787379

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells

Copyright and License information Disclaimer

Abstract

We have isolated UV light-induced and spontaneous tumors along with nonmalignant cells and tissues from each host. CD8+ CTL clones generated to a number of highly immunogenic UV-induced tumors did not react with autologous normal fibroblasts nor with autologous second tumors. Using up to 25 independently induced tumors as targets, these CTL clones were found to be uniquely specific for the particular tumor used for immunization even when multiple tumors isolated from the same animals were used as targets. In addition to this extensive antigenic diversity of independently induced tumors, we found that a single cancer cell can express multiple independent antigens that were uniquely expressed on the tumor but were not detectable on autologous nonmalignant fibroblasts. A poorly immunogenic spontaneous tumor was also found to express an antigen that was uniquely specific for the immunizing tumor in that it was absent from any of 25 other tumors tested. This antigen was recognized by a mAb and not detected on autologous nonmalignant fibroblasts or on an autologous second spontaneous tumor. These findings demonstrate that syngeneic CTL clones or mAbs can define unique antigens on UV-induced or spontaneous tumors. The use of autologous nonmalignant fibroblast targets made it unlikely that these antigens were widely expressed on normal cells. The availability of cloned immunological probes to antigens on tumors isolated with autologous normal cells will allow a reliable identification of the genetic origins of unique antigens on experimentally induced and spontaneous tumors and permit a decisive answer to whether these unique antigens are encoded by normal genes or by genes that have undergone somatic mutations; i.e., whether these antigens are truly tumor specific.

Full Text

The Full Text of this article is available as a PDF (1.1M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • FOLEY EJ. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953 Dec;13(12):835–837. [Abstract] [Google Scholar]
  • PREHN RT, MAIN JM. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [Abstract] [Google Scholar]
  • KLEIN G, SJOGREN HO, KLEIN E, HELLSTROM KE. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960 Dec;20:1561–1572. [Abstract] [Google Scholar]
  • Stauss HJ, Linsk R, Fischer A, Watts S, Banasiak D, Haberman A, Clark I, Forman J, McMillan M, Schreiber H, et al. Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma. J Immunogenet. 1986 Apr-Jun;13(2-3):101–111. [Abstract] [Google Scholar]
  • Stauss HJ, Van Waes C, Fink MA, Starr B, Schreiber H. Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer. J Exp Med. 1986 Nov 1;164(5):1516–1530. [Europe PMC free article] [Abstract] [Google Scholar]
  • Linsk R, Vogel J, Stauss H, Forman J, Goodenow RS. Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma. J Exp Med. 1986 Sep 1;164(3):794–813. [Europe PMC free article] [Abstract] [Google Scholar]
  • Lee DR, Rubocki RJ, Lie WR, Hansen TH. The murine MHC class I genes, H-2Dq and H-2Lq, are strikingly homologous to each other, H-2Ld, and two genes reported to encode tumor-specific antigens. J Exp Med. 1988 Nov 1;168(5):1719–1739. [Europe PMC free article] [Abstract] [Google Scholar]
  • Urban JL, Burton RC, Holland JM, Kripke ML, Schreiber H. Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells. J Exp Med. 1982 Feb 1;155(2):557–573. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kripke ML. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res. 1977 May;37(5):1395–1400. [Abstract] [Google Scholar]
  • Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst. 1974 Nov;53(5):1333–1336. [Abstract] [Google Scholar]
  • Wortzel RD, Urban JL, Philipps C, Fitch FW, Schreiber H. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones. J Immunol. 1983 May;130(5):2461–2466. [Abstract] [Google Scholar]
  • Glasebrook AL, Fitch FW. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med. 1980 Apr 1;151(4):876–895. [Europe PMC free article] [Abstract] [Google Scholar]
  • Weiss A, Brunner KT, MacDonald HR, Cerottini JC. Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens. J Exp Med. 1980 Nov 1;152(5):1210–1225. [Europe PMC free article] [Abstract] [Google Scholar]
  • Cerottini JC, Engers HD, Macdonald HR, Brunner T. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med. 1974 Sep 1;140(3):703–717. [Europe PMC free article] [Abstract] [Google Scholar]
  • Lemke H, Hammerling GJ, Hohmann C, Rajewsky K. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature. 1978 Jan 19;271(5642):249–251. [Abstract] [Google Scholar]
  • Coffino P, Scharff MD. Rate of somatic mutation in immunoglobulin production by mouse myeloma cells. Proc Natl Acad Sci U S A. 1971 Jan;68(1):219–223. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kripke ML, Fisher MS. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst. 1976 Jul;57(1):211–215. [Abstract] [Google Scholar]
  • Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1688–1692. [Europe PMC free article] [Abstract] [Google Scholar]
  • Holland JM, Mitchell TJ, Gipson LC, Whitaker MS. Survival and cause of death in aging germfree athymic nude and normal inbred C3Hf/He mice. J Natl Cancer Inst. 1978 Nov;61(5):1357–1361. [Abstract] [Google Scholar]
  • Morison WL, Jerdan MS, Hoover TL, Farmer ER. UV radiation-induced tumors in haired mice: identification as squamous cell carcinomas. J Natl Cancer Inst. 1986 Nov;77(5):1155–1162. [Abstract] [Google Scholar]
  • GLOBERSON A, FELDMAN M. ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS. J Natl Cancer Inst. 1964 Jun;32:1229–1243. [Abstract] [Google Scholar]
  • Urban JL, Kripke ML, Schreiber H. Stepwise immunologic selection of antigenic variants during tumor growth. J Immunol. 1986 Nov 1;137(9):3036–3041. [Abstract] [Google Scholar]
  • Wortzel RD, Philipps C, Schreiber H. Multiple tumour-specific antigens expressed on a single tumour cell. Nature. 1983 Jul 14;304(5922):165–167. [Abstract] [Google Scholar]
  • Hewitt HB. The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res. 1978;27:149–200. [Abstract] [Google Scholar]
  • Uyttenhove C, Maryanski J, Boon T. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med. 1983 Mar 1;157(3):1040–1052. [Europe PMC free article] [Abstract] [Google Scholar]
  • Philipps C, McMillan M, Flood PM, Murphy DB, Forman J, Lancki D, Womack JE, Goodenow RS, Schreiber H. Identification of a unique tumor-specific antigen as a novel class I major histocompatibility molecule. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5140–5144. [Europe PMC free article] [Abstract] [Google Scholar]
  • Basombrío MA. Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene. Cancer Res. 1970 Oct;30(10):2458–2462. [Abstract] [Google Scholar]
  • Basombrío MA, Prehn RT. Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors. Natl Cancer Inst Monogr. 1972 Dec;35:117–124. [Abstract] [Google Scholar]
  • Wortzel RD, Urban JL, Schreiber H. Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2186–2190. [Europe PMC free article] [Abstract] [Google Scholar]
  • Basombrío MA, Prehn RT. Antigenic diversity of tumors chemically induced within the progeny of a single cell. Int J Cancer. 1972 Jul 15;10(1):1–8. [Abstract] [Google Scholar]
  • Embleton MJ, Heidelberger C. Antigenicity of clones of mouse prostate cells transformed in vitro. Int J Cancer. 1972 Jan 15;9(1):8–18. [Abstract] [Google Scholar]
  • Hood L, Huang HV, Dreyer WJ. The area-code hypothesis: the immune system provides clues to understanding the genetic and molecular basis of cell recognition during development. J Supramol Struct. 1977;7(3-4):531–559. [Abstract] [Google Scholar]
  • Srivastava PK, Old LJ. Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today. 1988 Mar;9(3):78–83. [Abstract] [Google Scholar]
  • Old LJ. Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res. 1981 Feb;41(2):361–375. [Abstract] [Google Scholar]
  • Lampson LA, Levy R. A role for clonal antigens in cancer diagnosis and therapy. J Natl Cancer Inst. 1979 Feb;62(2):217–220. [Abstract] [Google Scholar]
  • King W, Patel MD, Lobel LI, Goff SP, Nguyen-Huu MC. Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science. 1985 May 3;228(4699):554–558. [Abstract] [Google Scholar]
  • De Plaen E, Lurquin C, Van Pel A, Mariamé B, Szikora JP, Wölfel T, Sibille C, Chomez P, Boon T. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2274–2278. [Europe PMC free article] [Abstract] [Google Scholar]
  • Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987 May;84(10):3365–3369. [Europe PMC free article] [Abstract] [Google Scholar]
  • Middle JG, Embleton MJ. Naturally arising tumors of the inbred WAB/Not rat strain. II. Immunogenicity of transplanted tumors. J Natl Cancer Inst. 1981 Sep;67(3):637–643. [Abstract] [Google Scholar]
  • Vaage J. Nonvirus-associated antigens in virus-induced mouse mammary tumors. Cancer Res. 1968 Dec;28(12):2477–2483. [Abstract] [Google Scholar]
  • Morton DL, Miller GF, Wood DA. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas. J Natl Cancer Inst. 1969 Feb;42(2):289–301. [Abstract] [Google Scholar]
  • Carswell EA, Wanebo HJ, Old LJ, Boyse EA. Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst. 1970 Jun;44(6):1281–1288. [Abstract] [Google Scholar]
Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

Full text links 

Read article at publisher's site: https://doi.org/10.1084/jem.170.1.217

Read article for free, from open access legal sources, via Unpaywall: http://jem.rupress.org/content/jem/170/1/217.full.pdfUnpaywall

Citations & impact 

Impact metrics

66
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/5103451
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/5103451

Article citations

Go to all (66) article citations

Protocols & materials 

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

NCI NIH HHS (3)